dopamine agonists

Preferred Label : dopamine agonists;

MeSH definition : Drugs that bind to and activate dopamine receptors.;

MeSH synonym : agonists, dopamine receptor; agonists, dopamine; receptor agonists, dopamine; agonists, dopaminergic; dopamine receptor agonists; dopamine agonist; agonist, dopamine receptor; dopaminergic agonist; agonist, dopaminergic; agonist, dopamine; dopamine receptor agonist; receptor agonist, dopamine; dopaminergic agonists;

MeSH annotation : GEN or unspecified; prefer specifics; DF: DOPAMINE AGON or DOPAMINE AG;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D018491;

UMLS CUI

C0178601;

ATC code(s)
- dopamine agonists [ATC Code]
- pramipexole [ATC Code]
- ropinirole [ATC Code]
ATC code(s)
- dihydroergocryptine mesylate [ATC Code]
- dopamine agonists [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Dopamine agonists [Bloc CIM-11]
- Dopamine receptor agonist (disposition) [SNOMED CT concept]
CISMeF manual mappings
- Substance with dopamine receptor agonist mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Dopamine Agonist [NCIt concept]
- dopamine agonists [ATC Code]
Indexing information
- N-methyl-NNC 01-0259 [MeSH Supplementary Concept]
- OS-3-106 [MeSH Supplementary Concept]
- WW-III-55 [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- dopamine [MeSH Descriptor]
- receptors, dopamine [MeSH Descriptor]
Record concept(s)
- dopamine agonists [MeSH concept]
See also (suggested by CISMeF)
- receptors, dopamine [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing dopamine receptor agonist (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (3,4-dihydroxyphenylamino)-2-imidazoline [MeSH Supplementary Concept]
- 1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine [MeSH Supplementary Concept]
- 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine [MeSH Supplementary Concept]
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine [MeSH Descriptor]
- 2-(4-(2-cyanophenyl)-1-piperazinyl)-N-(3-methylphenyl) acetamide [MeSH Supplementary Concept]
- 2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin [MeSH Supplementary Concept]
- 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol [MeSH Supplementary Concept]
- 3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine [MeSH Supplementary Concept]
- 3-N-methylspiperone [MeSH Supplementary Concept]
- 7-hydroxy-2-N,N-dipropylaminotetralin [MeSH Supplementary Concept]
- A 68930 [MeSH Supplementary Concept]
- A 77636 [MeSH Supplementary Concept]
- ADTN [MeSH Supplementary Concept]
- Aripiprazole [MeSH Descriptor]
- BP 897 [MeSH Supplementary Concept]
- CY 208-243 [MeSH Supplementary Concept]
- Cabergoline [MeSH Descriptor]
- N-((4-(2-cyanophenyl)piperazinyl)methyl)benzamide [MeSH Supplementary Concept]
- N-(2-chloro-6-methylergoline-8-yl)-2,2-dimethylpropanamide [MeSH Supplementary Concept]
- N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride [MeSH Supplementary Concept]
- N-n-propylnorapomorphine [MeSH Supplementary Concept]
- NCQ 298 [MeSH Supplementary Concept]
- PD 158771 [MeSH Supplementary Concept]
- PF-06669571 [MeSH Supplementary Concept]
- Pramipexole [MeSH Descriptor]
- SK&F 77434 [MeSH Supplementary Concept]
- SK&F 81297 [MeSH Supplementary Concept]
- SK&F 82958 [MeSH Supplementary Concept]
- alnespirone [MeSH Supplementary Concept]
- apomorphine [MeSH Descriptor]
- brexpiprazole [MeSH Supplementary Concept]
- bromocriptine [MeSH Descriptor]
- carbidopa, levodopa drug combination [MeSH Supplementary Concept]
- dihydrexidine [MeSH Supplementary Concept]
- dihydroergocornine [MeSH Descriptor]
- dihydroergocryptine [MeSH Descriptor]
- dihydroergotamine [MeSH Descriptor]
- dihydroergotoxine [MeSH Descriptor]
- dironyl [MeSH Supplementary Concept]
- docarpamine [MeSH Supplementary Concept]
- dopexamine [MeSH Supplementary Concept]
- ergocryptine [MeSH Supplementary Concept]
- fananserin [MeSH Supplementary Concept]
- fenoldopam [MeSH Descriptor]
- ibopamine [MeSH Supplementary Concept]
- lisuride [MeSH Descriptor]
- mesulergine [MeSH Supplementary Concept]
- metergoline [MeSH Descriptor]
- naxagolide [MeSH Supplementary Concept]
- pergolide [MeSH Descriptor]
- piribedil [MeSH Descriptor]
- preclamol [MeSH Supplementary Concept]
- quinagolide [MeSH Supplementary Concept]
- quinelorane [MeSH Supplementary Concept]
- quinpirole [MeSH Descriptor]
- ropinirole [MeSH Supplementary Concept]
- rotigotine [MeSH Supplementary Concept]
- roxindole [MeSH Supplementary Concept]
- stepholidine [MeSH Supplementary Concept]
- talipexole [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Dopamine Agonist [NCIt concept]
- Product containing dopamine receptor agonist (product) [SNOMED CT concept]
- Substance with dopamine receptor agonist mechanism of action (substance) [SNOMED CT concept]
- dopamine agonists [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients